Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire (Q37868009)

24 August 2017

Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire (English)

1 reference

chronic obstructive pulmonary disease

24 August 2017

1 reference

1 reference

1 reference

Scott M Montgomery

4

0 references

Christer Janson

series ordinal

5

object named as

Christer Janson

1 reference

24 August 2017

Josefin Sundh

1

1 reference

24 August 2017

Björn Ställberg

series ordinal

2

1 reference

24 August 2017

Karin Lisspers

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

22 April 2011

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

3

1 reference

24 August 2017

173-181

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Quality of life measurement for patients with diseases of the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Gender and COPD in patients attending a pulmonary clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

The influence of co-morbidity on health-related quality of life in asthma and COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Added value of co-morbidity in predicting health-related quality of life in COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

A measure of quality of life for clinical trials in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Development, validity and responsiveness of the Clinical COPD Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Impact on patients' health status following early identification of a COPD exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Study of the burden on patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Asthma control in primary care in Sweden: a comparison between 2001 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

How often is diagnosis of COPD confirmed with spirometry?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Validation of the clinical COPD Questionnaire (CCQ) in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Co-morbid association of depression and COPD: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Quality of life in an urban Asian population: the impact of ethnicity and socio-economic status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Gender associated differences in determinants of quality of life in patients with COPD: a case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Association of chronic obstructive pulmonary disease and sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Attaining a correct diagnosis of COPD in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

The Brussels Declaration: the need for change in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.560130

10.3109/15412555.2011.560130

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference